National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Stomach (Gastric) Cancer Prevention (PDQ®)
Patient Version   Health Professional Version   Last Modified: 03/13/2008



Purpose of This PDQ Summary






Summary of Evidence






Significance






Evidence of Benefit






Get More Information From NCI






Changes To This Summary (03/13/2008)






Questions or Comments About This Summary






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

New Study of Targeted Therapies for Breast Cancer

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Summary of Evidence

Dietary Factors
Helicobacter Pylori Infection
Chemoprevention

Note: Separate PDQ summaries on Stomach (Gastric) Cancer Screening, Gastric Cancer Treatment, and Levels of Evidence for Cancer Screening and Prevention Studies are also available.

Dietary Factors

Based on fair evidence, excessive salt intake and deficient dietary consumption of fresh fruits and vegetables are associated with an increased risk of gastric cancer. Dietary intake of vitamin C contained in vegetables, fruits, and other foods of plant origin is associated with a reduced risk of gastric cancer. Diets high in whole-grain cereals, carotenoids, allium compounds, and green tea are also associated with a reduced risk of this cancer. However, it is uncertain if changing one's diet to include more vegetables, fruits, and whole grains would reduce the risk of gastric cancer.

Description of the Evidence

  • Study Design: Evidence obtained from cohort or case-control studies.
  • Internal Validity: Good.
  • Consistency: Small number of studies.
  • Magnitude of Effects on Health Outcomes: Small, difficult to determine.
  • External Validity: Fair (populations vary greatly in their underlying nutritional status).
Helicobacter Pylori Infection

Based on solid evidence, Helicobacter pylori infection is associated with an increased risk of gastric cancer, however, the evidence is inadequate to determine if treatment with antibiotics reduces the risk of developing gastric cancer.

Description of the Evidence

  • Study Design: Evidence obtained from cohort or case-control studies.
  • Internal Validity: Good.
  • Consistency: Good, multiple studies.
  • Magnitude of Effects on Health Outcomes: Increased risk, moderate magnitude.
  • External Validity: Good.
Chemoprevention

The evidence is inadequate to determine if dietary or antibiotic interventions will reduce the risk of developing gastric cancer. A chemoprevention trial in China reported a statistically significant reduction of gastric cancer mortality after supplementation with beta carotene, vitamin E, and selenium.

Description of the Evidence

  • Study Design: Evidence obtained from randomized controlled trials.
  • Internal Validity: Fair.
  • Consistency: Poor.
  • Magnitude of Effects on Health Outcomes: Cannot determine.
  • External Validity: Fair.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov